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Abstract
The stratum lacunosum moleculare (SLM) is the connection hub between entorhinal cortex and hippocampus, two brain
regions that are most vulnerable in Alzheimer’s disease. We recently identified a specific synaptic deficit of Nectin-3 in
transgenic models for tauopathy. Here we defined cognitive impairment and electrophysiological problems in the SLM of
Tau.P301L mice, which corroborated the structural defects in synapses and dendritic spines. Reduced diffusion of DiI from
the ERC to the hippocampus indicated defective myelinated axonal pathways. Ultrastructurally, myelinated axons in the
temporoammonic pathway (TA) that connects ERC to CA1 were damaged in Tau.P301L mice at young age. Unexpectedly,
the myelin defects were even more severe in bigenic biGT mice that co-express GSK3b with Tau.P301L in neurons.
Combined, our data demonstrate that neuronal expression of protein Tau profoundly affected the functional and structural
organization of the entorhinal-hippocampal complex, in particular synapses and myelinated axons in the SLM. White matter
pathology deserves further attention in patients suffering from tauopathy and Alzheimer’s disease.
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Introduction
Deteriorating intellectual and mental faculties are all but the
most feared in the elderly in our ageing society. Despite extensive
fundamental and clinical investigations and trials, the lack of
preventive or effective treatment of neurodegenerative disorders
accounts for the increasing number of people suffering from
dementia, in particular Alzheimer’s Disease (AD) [1]. Besides the
well-known defects in gray matter, also problems with white
matter are recognized in AD. These include structural defects in,
with partial to extensive loss of myelin sheaths, inflicting axons
with microstructural changes that remain largely to be defined [2–
9]. Interestingly, myelin defects observed in the perforant pathway
(PP) strengthened the hypothesis that pathologically altered
anatomical pathways contribute importantly to mental disease
[6,7,10].
The entorhinal cortex (ERC) is considered an early and most
vulnerable region in AD-brain. Accumulation of phosphorylated
protein tau in all its layers precedes its progressive accumulation in
the hippocampal formation [11,12]. ERC and hippocampus are
intimately involved in various forms of learning and memory that
are affected in AD, which make entorhinal-hippocampal projec-
tions of prime interest, both functionally and in relation to the
proposed ‘spreading’ or sub-regional progression of tauopathy
[13–17].
ERC-neurons project to the dentate gyrus (DG) and CA1
hippocampal subfields by the perforant (PP) and temporoammonic
pathway (TA) that originate in ERC layers II and III, respectively
[18,19]. The TA pathway links ERC to CA1 pyramidal neurons
by synapsing onto distal parts of apical dendrites within the
stratum lacunosum moleculare (SLM) [20]. Although most
afferents in CA1 SLM constitute the TA with afferents from
ERC layers II and III, also ERC layers V and VI contribute [19].
Early in AD, the apical dendrites in SLM develop phospho-tau
positive dilatations resulting in degeneration, termed dendritic
amputation [21].
Attention has been focused mainly on PP that targets DG, while
TA remained relatively neglected, even so far that the term PP
usually also refers to TA. Nevertheless, TA was defined of prime
importance for long-term memory consolidation and for interme-
diate-term memory retention and retrieval [22–24].
Recently we reported that expression of Nectin-3, an important
cell adhesion molecule (CAM) was compromised in the CA1 SLM
of two transgenic models for tauopathy, carrying Tau.P301L
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without or with GSK3b [25]. We now tested the hypothesis that
early phases of tauopathy impact the structure and functions of
synapses and dendritic spines in the ERC-hippocampal formation
of the Tau.P301L and biGT models. The combined data
demonstrated that tauopathy provoked early and profound
impairments of the functional and structural organization of the
hippocampal circuits that link ERC to the hippocampus proper, in
particular synapses and myelinated axons within the SLM.
Materials and Methods
Ethical statement
All experiments were performed in accordance with regional,
national and European regulations concerning animal welfare and
animal experimentation, and were authorized and supervised by
the University animal welfare commission (Ethische Commissie
Dierenwelzijn, KULeuven).
Mouse models
Generation and validation of Tau.P301L mice and bigenic
Tau.P301LxGSK3b.S9A mice (denoted biGT) were reported
[26,27]. Analysis of dendritic spines was performed in crosses with
Thy1-YFP mice, as described [28,29]. All offspring was genotyped
for the respective transgenes by PCR and qPCR on DNA isolated
from tail biopsies [25,27,29].
Intracerebral injection of AAV-Tau.4R in the entorhinal cortex
was as described [30,31]. Briefly, AAV-Tau.4R virus (108
transducing unit) was stereotactically injected at coordinates
posterior 4.72 mm, lateral 3.25 mm, ventral 3.5 mm relative to
Bregma, and injected mice were analyzed 1 month post-injection.
Behavior
Passive Inhibitory avoidance task (PIA) was performed in
a two-chambered inner box comprising lit and dark sections
separated by a trap-door, all placed inside a larger sound-tight
box. For conditioning mice were placed in the lit section and after
10 sec the trap-door was opened to allow entrance in the dark
section where they received an electric footshock (0.5 mA; 2 sec)
after 2 sec. The mice were kept 15 sec in the dark compartment
before being returned to the home cage. Retention was assessed
after 24 hours by placing the mouse in the lit section and
measuring the latency as the time that elapsed before entry into
the dark compartment [27].
Novel Object recognition task (NORT) was essentially as
described [32–34]. Briefly, mice were habituated for 10 min in the
perspex open-field box dimly illuminated from below. The next
day, mice were observed in the same box for 8 min in the presence
of two identical objects (A). The time was recorded that the mice
explored both objects with criterion that the snout was directed
towards and close to the object (less than 1 cm). The exploration
time was recorded as the measure for explorative behavior. The
same day, 4 hours later an 8 min retention trial was performed by
placing the mouse in the box with one old (A) and a novel object
(B). The time that the animal spent exploring each object (tA, tB)
was recorded. The relative retention index (RI) was defined as the
time spent exploring novel object (B) over the time spent exploring
both objects, i.e. tB/(tA+tB)6100.
Biochemical analysis
Mice were sacrificed by decapitation and the brain rapidly
removed, hippocampi promptly dissected and homogenized as
described [25]. Proteins were denatured, reduced and separated
on 10% Tris-Glycine SDS-PAGE gels (Anamed, Germany). After
transfer, nitrocellulose membranes were probed with primary
antibodies specific for protein tau and tubulin as described [25]
and for CNPase (Millipore - MAB326) as marker for myelin.
Immunohistochemistry
Mice were anesthetized (Nembutal; 100 mg/kg, i.p.) before
transcardiac perfusion with ice-cold saline (4 ml/min, 2 min).
Brains were quickly removed to allow an overnight fixation in
4%paraformaldehyde in PBS at 4uC. Brains were stored in 0.1%
sodium azide in PBS at 4uC until vibratome 40 mm thick sections
were collected.
Immunohistochemistry was performed essentially as described
[26,30]. For CNPase (Millipore - MAB326) an antigen retrieval
step was necessary. Briefly, sections were mounted on silanized
glasses, dried for one hour at 37uC and incubated in a decloaking
chamber in proprietary decloaking solution (Diva, Biocare
Medical). After rinsing in PBS, sections were pretreated for
15 min in a 1.5% H2O2 in 50% methanol/PBS to suppress
endogenous peroxidase activity. Next, blocking of nonspecific
binding sites was by incubation in blocking buffer (10% fetal calf
serum, 0.1% Triton X-100 in PBS). The sections were incubated
at 4uC overnight with primary monoclonal antibodies: HT7 and
AT100 (Innogenetics, Gent), AT180 and AT8 (Thermo Scientific),
appropriately diluted in blocking buffer.
After rinsing in 0.1% Triton X-100 in PBS, sections were
incubated for 1 hr with the appropriate secondary antibodies
(1:500 in blocking buffer). Alternatively as required, sections were
incubated with avidin-biotin complex (Vector Laboratories -
Vectastain ABC Elite kit) for 30 min, rinsed in PBS and incubated
for 5 min in 50 mM Tris-HCl (pH7.6). Enzymatic staining was
performed using a solution of 3,39-diaminobenzidine (0.5 mg/ml),
0.3% H2O2 in 50 mM Tris-HCl (pH 7.6). Hematoxylin counter-
staining was prior to dehydration in a graded ethanol series. After
two washes in 100% xylol, the sections were mounted with
DePeX. Quantification of IHC staining was performed blindly,
assigning ascending scores from 0 to 2, for negative to intense
staining, respectively.
CA1 SLM Tracking with DiI crystals implanted in the
entorhinal cortex
Mice were anesthetized (Nembutal; 100 mg/kg, i.p.) before
transcardiac perfusion with ice-cold saline (4 ml/min, 2 min)
followed by 4% paraformaldehyde perfusion (4 ml/min, 10 min).
Brains were removed and post-fixed by immersion in 4%
paraformaldehyde at 4uC for 3 days. A single crystal of the
carbocyanine 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocya-
nine perchlorate (DiI, D-3911, Invitrogen) [35,36] was implanted
in the entorhinal cortex at coordinates: 5 mm posterior to bregma,
2.8 mm lateral to midline and 3 mm ventral, determined using a
Vernier caliper. Brains were stored in 4% paraformaldehyde at
room temperature for 14 months, to allow the dye to diffuse. After
rinsing the brains in PBS, vibratome sections (40 mm) were cut and
mounted on glass slides under coverslip, in 65% glycerol in PBS
[37]. Microscopic images were collected (Leica microscope with
appropriate filters). Higher magnifications were acquired by
confocal microscopy (Olympus Fluoview 1000). Quantification
was performed with dedicated software (Qwin, Leica).
CMC myelin tissue staining
Sagittal free-floating sections (40 mm) from the same brains used
for DiI tracings were incubated for myelin staining with
3-(4-aminophenyl)-2H-chromen-2-one (CMC) [38]. Briefly, sec-
tions were incubated in 1% H2O2 in 10% Triton X-100 (in PBS)
for 10 minutes, before 30 min incubation at room temperature
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with 100 mM CMC (#9869 Matrix Scientific) in 1% DMSO
diluted in PBS. Sections were rinsed with PBS three times for 5
minutes before microscopic analysis.
Dendritic spines
Dendritic spines were analyzed as published [29] by confocal
microscopy (Olympus Fluoview 1000) in the region of interest,
CA1 SLM in brain of Tau.P301LxYFP bigenic mice. In total 9
independent images per mouse from 5 mice per genotype were
acquired and analyzed on confocal z-stacks (0.3 mm) without post-
processing. Spines were defined visually and counted manually.
Spine density is expressed as the number of spines per 10 mm
length of dendrite. Spine maturation index is defined as the ratio
of mushroom spines to all other spine types, with mushroom spines
defined by the spine head at least twice as wide as the spine neck
[29].
Electron microscopy-ultrastructure analysis
Mice were anesthetized (Nembutal; 100 mg/kg, i.p.) before
transcardiac perfusion with ice-cold saline (4 ml/min, 2 min)
followed by perfusion with Karnovsky fixative for 10 minutes.
Brains were quickly removed and fixed in Karnovsky solution for 5
days. Thick vibratome sections (300 mm) were incubated in 1%
OsO4 solution at room temperature prior to dehydration in a
graded ethanol series, and finally embedded in agar100 epoxy
resin. Regions of interest were trimmed and 70 nm serial sections
were cut using a diamond knife (Reichert ultramicrotome).
Sections were collected on formvar-coated single slot grids.
The CA1 SLM region was explored for spines at 4000x
magnification (Jeol JEM 1400 microscope) and for myelin
structural analysis at 25000x magnification (Jeol JEM 1010
microscope). Spine reconstruction was performed based on
ribbons composed of at least 25 serial sections (70 nm thick),
and from 10 different areas within the CA1 SLM. Serial sections
were aligned (sEM software), and spine and PSD contours were
delineated manually (Reconstruct software, http://synapses.clm.
utexas.edu), allowing 3D reconstruction of each structure of
interest. Spine density was assessed using the optical dissector for
mushroom, thin spines and shaft synapses. Spine volume, PSD
parameters and spine length were calculated by the same software.
Mushroom, thin and stubby spines were categorized following
similar criteria [39], with threshold set to 250 nm for spine heads
to distinguish mushroom from thin spines.
Myelin structure in CA1 SLM and TA pathway was analyzed in
at least 20 image per mouse, which in total contained more than
300 axons representing between 1.5 to 2 mm of myelin sheath.
The G-ratio of inner axonal diameter over the total outer diameter
including myelin was measured on the same myelin axonal
structures.
Electrophysiology
Acute hippocampal slices were prepared as described [40].
Briefly, brains were quickly removed and cut horizontally into
250 mm slices in ice-cold artificial cerebrospinal fluid (ACSF)
containing (in mM) 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2,
1.25 KH2PO4, 25 NaHCO3, and 25 glucose, saturated with
95% O2/5% CO2 (pH 7.2–7.3). The CA3 and DG regions were
sectioned to separate the SLM layer of the CA1 region from the
trisynaptic circuit. Sectioned slices were incubated in a recovery
chamber containing oxygenated ACSF at room temperature for at
least two hour before recording.
Extracellular stimulation and recordings were performed using
a multi-electrode array (MEA) (Multi Channel Systems, Martins-
ried, Germany) as described [40]. Sections were continuously
perfused with oxygenated ACSF (3 ml/min) at 31uC containing
20 mM bicuculline to block fast inhibitory transmission. TA was
stimulated by electrodes positioned under SLM near the
hippocampal fissure. Evoked field excitatory postsynaptic poten-
tials (fEPSPs) were monitored [41,42]. Input/Output curves were
generated by collecting responses to a series of increasing biphasic
voltage pulses of 200 ms duration. The stimulus intensity used in
subsequent recordings was set to evoke fEPSP of 50% of maximal
amplitude. Short-term plasticity was addressed before LTP
induction. Paired-pulse facilitation (PPF) was evaluated using two
stimulations at inter-pulse intervals (IPI) between 20 and
500 msec. Short-term depression was assessed by measuring
fEPSP amplitude in response to a train of pulses at 100 Hz.
LTP was induced, after recording a stable baseline for 15 min, by
4 trains of high frequency stimulation (HFS) at 100 Hz for 1 sec
with 20 sec intervals. At the end of the recordings, the mGluR2
agonist 2-(2,3-dicarboxycyclopropyl)glycine (DCG IV, Tocris,
UK), was routinely added (3 mM final concentration) to verify
TA responses [42,43]. All MEA data were collected at 10 kHz
sampling frequency and 1100 amplifier gain. fEPSPs were
recorded and analyzed by dedicated software (MC_Rack &
MC_Data Tool software, Multi Channel Systems, Germany).
Statistical analysis
Statistical analysis was performed using dedicated software
(GraphPad Prism v5.03; San Diego, CA). Data were plotted as
median (for scoring) or mean6SEM. Data-sets were analyzed
either by Student’s t-test (unpaired, two-tailed) or One-way
ANOVA, followed by Bonferroni post hoc test as indicated in the
figure legends. For electrophysiological experiments, data (mean6
SEM) from transgenic and wild-type mice were compared by One-
or Two-way ANOVA (Origin 8.0, Origin Lab). Statistical
significance was defined as p,0.05.
Results
Most recently, we demonstrated that neuronal expression of
human protein Tau, either wild-type or mutant, engendered
pronounced and specific reduction of Nectin-3, the major synaptic
cell adhesion molecule (CAM) [25]. The defect was most
pronounced in the SLM, the connection hub between ERC and
hippocampus proper, two brain regions at the center of attention
in clinical and experimental studies in AD. The ERC projects by
myelinated axons forming the TA to the CA1 SLM by excitatory
synapses on distal sections of the apical dendrites of the CA1
pyramidal neurons.
Here we studied the early functional and structural repercus-
sions of tauopathy in the preclinical models, denoted Tau.P301L
and biGT mice, from early age (3 months) when significant
Nectin-3 expression was already lost, prior to the more classical
tangle tauopathy [25]. We investigated the surmised relation of
lacking Nectin-3 to impaired cognition in Tau.P301L mice. We
subsequently measured density and morphology of dendritic
spines, as well as their post-synaptic densities (PSD), all prime
structural parameters of synaptic plasticity, essential for learning
and memory [29,44,45].
We went on to define progression of Tauopathy in the Tau.P301L
mice and comparatively also in the other validated model for
tauopathy: bigenic Tau.P301LxGSK3b.S9A mice, denoted biGT.
Both models present with tauopathy progressing with age but on
different time-scales: age 7–11 months for Tau.P301L mice, and 10–
18 months for biGT mice [26,27]. Besides age of onset, both models
present regional differences in their intensity of eventual tauopathy
[26,27,29,46–50]. Nevertheless, the terminal phase was very similar
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in both models, despite the age difference, by combination of clinical
indices that progress rapidly (2–3 weeks) leading to death: reduction
in bodyweight, increased clasping of hind- and then fore-limbs,
hyperkyphosis and inactivity, upper airway dysfunction caused by
defective brainstem circuits [46,50,51]. The endpoint was invariably
precocious death, for Tau.P301L mice mostly between age 8–12
months (average 9 months) without survivors beyond age 12 months
[29]. The age of death of biGT mice was less sharply defined,
ranging from 10 to 22 months [26,27,46,50,51]. The mechanistic
contributions of GSK3b in the biGT model to the delay in
tauopathy and to clinical phenotype are subject of ongoing studies.
Cognitive defects in ageing tau.P301L mice
Tau.P301L mice were analyzed for cognitive capacity in two tasks
of different complexity: the novel object recognition task (NORT)
and passive inhibitory avoidance (PIA). Both tasks do not depend
heavily on physical and motor abilities, which become compromised
in Tau.P301L mice, as in most Tau transgenic mice [26]. Moreover,
the NORT, as performed, measures predominantly hippocampal
plasticity [52]. PIA is a more complex task, involving not only the
hippocampus but also amygdala and cortical regions [53].
NORT demonstrated cognitive defects in ageing Tau.P301L
mice that approached but were not yet terminal and still devoid of
clasping (Fig. 1). Conversely, the PIA task revealed cognitive
defects in Tau.P301L mice already at young age. Some variation
with age was attributed to the complexity of the task and the
known involvement of different brain regions, differently attained
by the progressing tauopathy (Fig. 1). Of note, the molecular
characteristics of Tau.P301L differ in different brain regions and
change with age in terms of phosphorylation and aggregation [50].
Most interesting, the behavioral defects in Tau.P301L mice
correlated with defective Nectin-3 levels in CA1 SLM [25]. We
therefore engaged to approach functional and brain-structural
aspects, first in Tau.P301L mice, and then extended the analysis to
biGT mice, to define pathological contributions of GSK3b
[27,29,31].
Figure 1. Defective cognition of Tau.P301L mice at different ages. Analysis by novel object recognition (ORT) (upper panel) and passive
inhibitory avoidance (PIA) task (lower panel) of Tau.P301L mice at age 2 to 9 months compared to age-matched wild-type FvB mice. Student t-Test,
unpaired, two-tailed, n = 8 per age group. *p,0.05, ****p,0.0001.
doi:10.1371/journal.pone.0087605.g001
Tauopathy and Stratum Lacunosum Moleculare
PLOS ONE | www.plosone.org 4 February 2014 | Volume 9 | Issue 2 | e87605
Dendritic spines in CA1 SLM of Tau.P301L mice
The cognitive analysis implicated that synaptic plasticity was
already affected in young Tau.P301L mice, which was corrobo-
rated by analysis of dendritic spines in the SLM [29]. Spine density
was, however, not affected in sub-regions SO and SR of the
hippocampal formation of Tau.P301LxYFP mice up to age 6
months (Fig. 2A). We concluded that early stages of tauopathy did
not negatively affect the development and maintenance of
dendritic spines.
The spine maturation index, defined as the ratio between the
density of mushroom spines to all other spines, is an index for active
and functional synapses [29,54]. Unexpectedly, in young Tau.P301L
mice the spine maturation index was increased, significantly in
stratum radiatum (SR), and borderline in stratum oriens (SO)
(p = 0.0068 and 0.0646, respectively; Student t-test unpaired, two-
tailed; Fig. 2A). In contrast, the spine maturation index tended to be
decreased in the SLM of Tau.P301L mice (Fig. 2A).
The morphology of mushroom and thin spines was analyzed in
ultrastructural detail by 3D reconstruction of electron micrographs
[39,55]. The results confirmed that the overall density of spines
was not significantly affected in young Tau.P301L mice relative to
wild-type mice, matched for age, gender and genetic background
(Table 1). Moreover, the ultrastructural data on Tau.P301L mice
corroborated the foregoing spines dataset obtained by confocal
microscopy in Tau.P301LxYFP mice: the density of mushroom
spines in SLM was significantly lower in young Tau.P301L mice
than in wild-type mice (age 4 months; p = 0.0037; Student t-Test
unpaired, two-tailed; Table 1). The volume of mushroom spines
was not affected in Tau.P301L mice, while a trend of decreased
volume of thin spines was noted (Table 1). The third parameter
analyzed, the mean overall length of mushroom and thin spines
within the CA1 SLM was similar in both genotypes.
Interestingly, both the area and the volume of the post-synaptic
density (PSD) were larger in mushroom spines in the SLM of
Tau.P301L mice compared to wild-type mice (p = 0.0177 and
p = 0.0138, respectively; t-Test; Table 1). Of note, a compensatory
increase in PSD area was proposed based on higher than normal
levels of the PSD95 protein in brain of AD patients [56].
We concluded that dendritic spines were altered in the early
stages of progressive tauopathy in pre-clinical Tau.P301L mice.
These defects correlated with defective Nectin-3 levels, and fit the
context of their cognitive defects, all predating the development of
classical tauopathy defined by large intra-neuronal tau aggregates.
We therefore went on to characterize the status of phosphorylation
of protein tau, focusing mainly on the ERC and SLM regions, and
compared Tau.P301L to biGT mice in an attempt to define the
contributions of GSK3b.
Time-line of tauopathy parameters in hippocampal
sub-regions of Tau.P301L and biGT mice
In the hippocampal formation, the ERC communicates with the
hippocampus proper by the PP and TA projections that classically
Figure 2. Analysis of dendritic spines in SLM of Tau.P301L mice. A. Dendritic spines in Tau.P301Lx YFP bigenic mice (n = 5) in different brain
regions: stratum oriens (SO), stratum radiatum (SR), CA1 SLM as indicated in the captions. Upper panel: spine density is expressed as number of
spines per 10 mm of dendritic shaft. Statistical analysis by Student t-Test, unpaired, two-tailed: SO, p = 0.066; SR, p = 0.0068; SLM, p = 0.47. Lower
panel: spines maturation ratio, expressed as number of mushroom spines to all spines. Statistical analysis by Student t-Test, unpaired, two-tailed: SO,
p = 0.58; SR, p = 0.17; SLM, p = 0.87. B. Representative reconstructions of dendritic spines in wild-type FvB and Tau.P301L mice.
doi:10.1371/journal.pone.0087605.g002
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originate in ERC layers II and III respectively [19,57,58]. In AD,
the loss of neurons starts and becomes most extensive in the ERC
and CA1 [11,59–61]. The tri-synaptic pathway constitutes a major
feature of the hippocampal circuitry that is essential for learning
and memory (L&M), but also prime suspect for contributions to
spreading of pathology and cognitive defects in AD [11,19,60].
Tau pathology was analyzed by immunohistochemistry, first for
phospho-epitope pT231 defined by antibody AT180, because it is
one of the earliest markers for tauopathy in AD, and widely used
as clinical biomarker in CSF for early diagnosis [62–64]. We then
supplemented phospho-epitope pS199/S202-Tau define by anti-
body AT8 as another classical marker in general use for post-
mortem staging of brain tauopathy in AD, although not for as
CSF-biomarker in clinical diagnosis [11,12,60].
ERC. In both genotypes, and already at young age (3 months)
the pT231-Tau epitope was evident in many neurons in layer II of
the medial ERC (Fig. 3, upper left). In contrast, only some neurons
were immunoreactive in layer III of the lateral ERC, and even less
in the medial ERC (Fig. 3). With age, AT180 immunoreactivity
progressed in all ERC layers and all sub-regions in both
Tau.P301L and biGT mice, without marked differences with the
genotype until age 9 months, before mice entered the terminal
phase.
In terminal Tau.P301L mice, the ERC was mildly marked by
IHC with AT180, in contrast to terminal biGT mice in which the
ERC was heavily loaded with AT180 positive neurons (Fig. 3,
upper right). IHC with antibody AT8 yielded similar labeling to
AT180 in young Tau.P301L and biGT mice, but much more
positive neurons that also stained more densely in ERC and
hippocampus of terminal biGT mice than in terminal Tau.P301L
mice (Fig. 3).
We concluded that not the terminal phenotype, but old age was
the more important determinant for tauopathy in the ERC of the
Tau.P301L and biGT mice, which is reminiscent of the fact that
ageing is the most important determinant in AD.
CA1 and SLM. Pyramidal neurons in CA1 of Tau.P301L and
biGT mice stained uniformly positive by IHC with AT180,
demonstrating that protein Tau.P301L became readily and
similarly phosphorylated at the pT231 epitope in both genotypes,
and already at young age. Neither age, nor terminal stage
markedly affected the phosphorylation of protein Tau at T231
(Fig. 3, Fig. 4A). Of note, CA1 neurons in wild-type FvB mice
remained completely devoid of immunoreaction for this epitope,
even at old age.
In the SLM, AT180 immunoreactive neuronal processes in both
Tau.P301L and biGT mice were evident already at young age,
without marked age-dependent changes (Fig. 3, Fig. 4A). Inter-
estingly, the reduction in AT180 immunoreactivity in terminal
biGT mice was fully accounted for by the extensive neurodegen-
eration in the CA1 sub-region bordering the subiculum (Fig. 3, red
asterisk; Fig. 4A).
We similarly analyzed phospho-epitope pS199/S202-Tau
defined by antibody AT8 for evolution with age. AT8 staining
was less intense than AT180 in SLM of Tau.P301L mice, except in
terminal mice (Fig. 4). Unexpected was the lesser AT8 reactivity in
the SLM of biGT mice relative to age-matched Tau.P301L mice
(Fig. 4). Clearly, neuronal tracts in the SLM of ageing biGT mice
remained longer devoid of the AT8 epitope, which became more
intense only in old, terminal biGT mice (13–18 months). Even
then, AT8 immunoreaction remained less pronounced than in
terminal, but younger Tau.P301L mice (Fig. 4B).
The combined data demonstrated that the progression of
phosphorylation of protein Tau leading to tauopathy was
particularly evident in the medial and lateral ERC and in the
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hippocampal sub-regions, including the SLM with its myelinated
axons from ERC. We concluded that the tauopathy in the SLM
differentiated Tau.P301L and biGT mice with respect to two
major phospho-epitopes, AT8 and AT180. Nevertheless, because
of inherent higher GSK3b activity in biGT mice, the anticipated
higher levels of AT180 and AT8 reflecting more extensive
phosphorylation of protein Tau by GSK3b was not substantiated
by the experimental observations.
Electrophysiology of synapses in SLM
The unexpected negative contribution of GSK3b in biGT mice
to the levels of phospho-epitopes and to the delayed tauopathy,
would be substantiated by biochemical examination, which is
evidently not possible for the tiny sub-regions of the hippocampus.
Therefore, we engaged to define functional and structural
parameters and defects inflicted by tauopathy to the hippocampal
formation, concentrating in particular on the SLM sub-region.
Synaptic activity in the SLM was examined ex vivo in brain
sections of two age-groups of Tau.P301L and biGT mice,
respectively 4–6 and 9–10 months, and compared to wild-type
FvB mice, matched for age and gender and with the identical
genetic background. Evoked fEPSPs were recorded in the SLM of
CA1 by stimulating ERC efferent axons (Fig. 5A). Responses at
SLM synapses were recorded without contamination from the SC
synapses by surgical sectioning the SC CA1 pathway. Stimulation
of the TA pathway evoked negative (sink) and positive (source)
fEPSPs in SLM and SR, respectively [41,42,65]. Selective blocking
of excitatory transmission at TA synapses with DCG IV, a specific
mGluR2 agonist [42,43] reduced nearly completely the evoked
fEPSPs, confirming that TA responses were recorded.
We measured LTP using our standard protocol of stimulation: 4
trains of 100 Hz pulses of 1 sec each, separated 20 sec apart. We
successfully induced LTP in all three genotypes, with the expected
amplitude at SLM synapses [41]. LTP at SLM synapses in young
and old Tau.P301L mice was similar to those in age-matched
Figure 3. Timeline of phospho-Tau in hippocampal formation of Tau.P301L and biGT mice. IHC for pT231-Tau (AT180) and pS199–202
(AT8) in the sub-regions of the hippocampal formation of Tau.P301L and biGT mice at 3 months of age and at terminal stage (see text for details). Red
asterisk marks CA1 pyramidal layer degeneration. Images are representative for the median levels of AT180 and AT8 staining (n = 6–8 mice per age
group). Denoted are layers I, II and III of the entorhinal cortex and CA1 hippocampal sub-regions stratum radiatum (SR) and stratum lacunosum
moleculare (SLM).
doi:10.1371/journal.pone.0087605.g003
Tauopathy and Stratum Lacunosum Moleculare
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e87605
wild-type FvB mice (Fig. 5B). Conversely, LTP was significantly
reduced in SLM of young biGT mice (Fig. 5B,D). In old biGT
mice, the LTP at SLM synapses was also decreased but did not
reach statistical significance because of the known inherent greater
variation of electrophysiological parameters in sections from old
mice (Fig. 6B, lower panel).
Basal synaptic transmission was measured by compilation of
Input/Output (I/O) curves with stimulus strengths between 0.5
and 4 V. In young mice, the I/O data in both genotypes were
similar to wild-type mice (Fig. 6A, left panel). In old biGT mice
(age 9–10 months) the fEPSP initial slopes were significantly
decreased, whereas again, old Tau.P301L mice did not differ from
age-matched wild-type mice (Fig. 6A, right panel).
Interesting in this context was the observation that in about
40% of old biGT mice, fEPSP could not be recorded in
hippocampal subfields SLM, SR and DG because the amplitudes
were below the detection limit set at peak-to-peak amplitude
,50 mV using 2V stimuli for 200 ms (Table 2). The biGT mice
clearly displayed an age-dependent disruption of basal activity at
the TA synapses, but also at the Schaffer collaterals and at PP
dependent synapses.
Short-term regulation of neurotransmitter release was measured
by paired-pulse facilitation (PPF) and short-term depression at TA
synapses. In young biGT mice, but not in young Tau.P301L mice,
PPF was significantly reduced, while in old mice (age 9–10
months) the TA synapses showed reduced facilitation in both
Tau.P301L and biGT mice, compared to wild-type mice (Fig. 6B).
Short-term depression was readily observed at TA synapses,
induced by 100 Hz pulses for 1 sec. In young mice (4–6 months),
short-term depression was not affected by either genotype, while in
older mice (9–10 months) short-term depression was less
pronounced in biGT mice (Fig. 6C).
Combined, the results demonstrated that Tau.P301L mice
showed normal baseline transmission and normal LTP, but
displayed reduced PPF at the SLM synapses. In contrast, synapses
in the SLM of biGT mice were deficient in base-line transmission,
and in short-term and long-term plasticity.
Analysis of white matter and myelinated axons
It was obvious from the current detailed analysis of ERC and
CA1 SLM that phosphorylation of protein tau was increased as
early as age 3 months in both models. Moreover, age-dependent
aggravation of tauopathy was demonstrated in the tri-synaptic
pathway, essential for learning and memory. Of note, late
hippocampal pathology, defined by IHC with AT100, was far
more extensive in biGT mice than in Tau.P301L mice [27,50],
which demonstrates the essential contribution of GSK3b, although
the molecular details and sub-regional differences remain to be
Figure 4. Timeline of phospho-Tau in the CA1 SLM of Tau.P301L and biGT mice. IHC for AT180 (A) and AT8 (B) staining in CA1 SLM region
of Tau.P301L and biGT mice at ages 3, 6 and 9 months and terminal. Data are represented as median intensity score for immunoreactivity with AT180
(A) and AT8 (B) in CA1 SLM. Grey symbols denote mice with clasping and black symbols denote terminal mice (see text for details)(n = 6–8 mice per
age group). CA1 hippocampal sub-regions stratum radiatum (SR) and stratum lacunosum molecular (SLM) are marked.
doi:10.1371/journal.pone.0087605.g004
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Figure 5. Electrophysiological analysis of LTP in SLM synapses in Tau.P301L and biGT mice. A. Image of hippocampal section on the MEA
chip, with superimposed fEPSPs recorded in the SLM (yellow oval) in response to stimulation of the TA pathway (white triangle). White solid lines
indicate where the section was cut to obtain pure TA responses. White dashed lines indicate granule and pyramidal cell body layers; black solid line
indicates the hippocampal fissure. Electrode 15 (white circle) was used as internal ground electrode. B. fEPSPs tracings (mean6SEM) recorded in SLM
in horizontal brain sections from young and old Tau.P301L and biGT mice. LTP was induced by 4 trains of high frequency stimulation (HFS) after
15 min of baseline recording. At the end of all recordings, DCG IV (3 mm) was added for 10 min. C. Representative tracings of fEPSPs at baseline
(grey), at 60 min after HFS (black) and 10 min after DCG IV (green). D. fEPSPs amplitudes recorded between 30 and 60 min after HFS in young and old
Tau.P301L and biGT mice (mean6SEM). Number of sections and mice: 4–6 months: FvB, n = 12 sections/8 mice; Tau.P301L, 11sections/6 mice; biGT 12
sections/6 mice; 9–10 months: FvB, n = 9 sections/6 mice; Tau.P301L 11 sections/6 mice; biGT, 8 sections/6 mice.
doi:10.1371/journal.pone.0087605.g005
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Figure 6. Electrophysiological analysis of SLM synapses in Tau.P301L and biGT mice. A. Basal synaptic transmission measured as the initial
slope of fEPSPs in response to increasing stimulus intensities in young (left panel) and old mice (right panel). Old biGT mice differed significantly from
Tauopathy and Stratum Lacunosum Moleculare
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defined. After we defined by AAV-Tau injection in the ERC that
protein Tau made use of both the TA and PP pathways to reach
the hippocampal formation (Fig. S1), we went on to assess the
effects of protein Tau alone and in combination with GSK3b on
the white-matter tracts within the CA1 SLM in both pre-clinical
tauopathy models.
Impaired diffusion of DiI from ERC to CA through
myelinated pathways. The reported electrophysiological data,
especially the affected paired pulse facilitation (PPF) strongly
implied presynaptic changes in Tau.P301L mice, exacerbated by
GSK3b in the biGT mice. In addition, Nectin-3, despite being
claimed as a post-synaptic CAM, was reported to co-localize with
myelinated axons, and therefore hypothesized to be essential for
TA myelinated axons [66,67]. Consequently, we investigated
presynaptic parameters for alterations of myelinated axons of the
TA pathway within CA1 SLM.
The carbocyanine dye DiI is the preferred tracer for long axonal
tracts, despite the drawback of slow diffusion, because its
distribution relies on lateral diffusion within the axonal mem-
branes, also in fixed tissues. Moreover, DiI labels myelin sheaths
over very long distances [68]. DiI crystals were implanted in the
ERC in fixed brains from adult pre-symptomatic Tau.P301L mice
(age 6–7 months) and age-matched wild-type FvB mice. Brains
were analyzed histologically after 14 months of incubation.
In wild-type mouse brain, the PP and TA were easily identified
by the bright staining of their axons (Fig. 7A). In contrast, in brain
from Tau.P301L mice, the intensity of staining of both TA and PP
axonal pathways was significantly reduced compared to wild-type
mice (Fig. 7). Also the alvear pathway (denoted AP in Fig. 7)
located below the corpus callosum (CC) was brightly stained in
wild-type mice, and significantly less in the brain of Tau.P301L
mice (Fig. 7C,D). Interestingly, both AP and TA originate in ERC
layer III and were observed to be similarly defective for DiI
diffusion, while PP was affected as well although originating in
ERC layer II. Obviously, all the major ERC-CA connections were
structurally and functionally compromised by neuronal expression
of protein Tau.P301L.
Defective myelination of TA axons in Tau.P301L,
exacerbated in biGT mice. The SLM comprises the projec-
tion of myelinated axons in the TA pathway that originate in the
ERC and synapse onto CA1 pyramidal neurons. Because myelin
sheaths are easily recognized ultrastructurally, we observed during
the ultrastructural analysis of spines, described in a foregoing
section, that myelin structures of TA axons in Tau.P301L mice
appeared damaged, already at the very young age of 4 months.
Surprisingly, the ultra-structure images showed many defective
myelin sheaths, referring to similar observations first in the brain of
aged primates, later also in elderly humans and AD patients
[2,69].
Operationally, we here defined myelin defects as sections of
axons surrounded by myelin sheaths that were malformed,
uncompacted, and presenting with split lamellae (Fig. 8A). The
G-ratio, defined as the ratio of the diameter of axon to that of the
total myelinated fiber, is the preferred parameter of myelinated
axons, with a normal value of around 0.77 in CNS of mice [70]. In
Tau.P301L mice, the G-ratio of TA axons was distributed around
the median of 0.70, with a small shift in distribution to lower
values compared to wild-type FvB mice (Fig. 8B; Table 3). In
contrast, in the SLM of biGT mice a significant deviation from the
mean G-ratio, with the median value decreased to 0.59, while
moreover the distribution was strongly skewed to lower values
(Fig. 8B, Table 3).
Additional parameters and means of quantification of the
observed myelin defects were applied to the TA axons in the SLM.
We first measured the relative number of TA axons that showed
myelin disruptions, which indirectly confirmed the data of the
G-ratio for the biGT mice but not for the Tau.P301L mice.
Indeed, despite the normal G-ratio observed in Tau.P301L mice, a
significant number of TA axons in the SLM were damaged with
respect to myelin structure compared to FVB mice (Fig. 8C, left
panel). Moreover, in biGT mice nearly all axons in the SLM were
covered by damaged myelin sheaths (85.863.6%; One-way
ANOVA: F(2,6) = 49.05, p = 0.0002; Fig. 8C, left panel).
The final parameter assessed for myelin defects in the SLM, the
relative length of disrupted axonal myelin sheaths indicated a
trend to increased length of damaged axons in Tau.P301L mice
(,10% of their length). Conversely, in biGT mice more than 50%
of the total length of the myelinated axons in the SLM contained
damaged myelin sheaths (One-way ANOVA: F(2,6) = 320.6,
p,0.0001; Fig. 8C, right panel).
CNPase as marker of defective myelinated TA axons in
Tau.P301L mice and biGT mice. We went on to molecularly
characterize the myelin defects in both transgenic models by
biochemical and immunohistological analysis of CNPase, a
myelin-associated enzyme that is among the first expressed in
differentiating oligodendrocytes that are responsible for myelina-
tion of axons in the CNS [71,72].
Biochemically, the two known isoforms of CNPase were
investigated and quantified by western blotting (Fig. 9A). In
Tau.P301L mice the levels of CNP2 were significantly decreased,
while CNP1 also tended to lower levels (Fig. 9A). In adult biGT
mice (age 6 months) the hippocampal levels of both the isoforms of
CNPase were significantly reduced (Fig. 9A). The ratio of the levels
of both CNPase isoforms was significantly lower in the
hippocampus of both Tau.P301L and biGT mice (Fig. 9A, right
panel).
IHC for CNPase in brain sections of young, old and terminal
mice of both genotypes, compared to wild-type FvB mice,
visualized the perturbations of myelin by weaker immunostaining
in the CA1 SLM of Tau.P301L and biGT mice (Fig. 9B). CNPase
immunoreactivity was mainly confined to the myelinated axons
within the SLM, implicating that the decrease in CNPase isoforms
detected biochemically, was contributed primordially by SLM
axons. Technically, it proved not possible to reliably quantify the
CNPase immunostaining to assign the decreased CNPase is in the
number of myelinated fibers or in their deficient myelination,
wild-type FvB mice: *p = 0.005. B. Paired-pulse facilitation are expressed as amplitude ratio of second to first peak. Tracings are averaged at 50 ms IPI
in young and old FvB, Tau.P301L and biGT mice. Statistical analysis at 4–6 months: *p = 0.021 biGT vs FvB; at 9–10 months: *p = 0.039 biGT vs FvB and
p= 0.004 Tau.P301L vs FvB.
doi:10.1371/journal.pone.0087605.g006
Table 2. Electrophysiological parameters.
FvB Tau.P301L biGT
Age (months) 4–6 9–10 4–6 9–10 4–6 9–10
success ratio (recorded/attempts) 12/12 9/9 11/11 11/11 12/12 8/14
number of mice 8 6 6 6 6 6
success-rate (%) 100 100 100 100 100 57
doi:10.1371/journal.pone.0087605.t002
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although the overall number of axons was not affected.
Conversely, the defective CNPase levels corroborated the DiI
diffusion data and the myelin defects, presented in the foregoing
sections.
The combined outcome illustrated not only the stronger effect
of the early stages of beginning tauopathy on the CNP2 isoform,
but also the synergistic impact of GSK3b with Tau.P301L on
axonal myelination in the hippocampus of the bigenic biGT mice,
with inherently higher GSK3b activity. The combined data-sets
demonstrated that myelination of axons within the TA was already
altered at young age in Tau.P301L mice, and that this clinical
phenotype was dramatically aggravated by co-expression of
GSK3b with Tau.P301L in the biGT mice.
Discussion
Indications that tauopathy, and pathological components of
AD, originate in the trans-entorhinal cortex were proposed long
ago [11]. To unravel the elusive molecular mechanisms that act
early in sporadic AD, we need to define and understand the
temporal and spatial origin and progression of the molecular
changes in amyloid and protein tau and their associated
pathology. Mouse models are most informative to define
parameters that with current technologies are impossible to
address in humans.
Protein Tau and the ERC-SLM-CA1 connection
Here we addressed the functional and structural problems
caused by tau pathology in the entorhinal cortex and hippocampus
in our two validated tauopathy models [25–27,46,49,51,52]. We
established that increased phosphorylation of protein tau was
evident in neurons in the medial and lateral entorhinal cortex.
Interestingly, the lateral ERC layer III was affected at younger age
than the medial ERC, as observed in patients [12]. The
observations were extended from the Tau.P301L mice to the
bigenic biGT mice that contain the same homozygous Tau.P301L
transgenic make-up, with the extra addition of one allele of the
GSK3b.S9A transgene [25,27,73].
Phosphorylation of protein Tau was prominent in the SLM in
both models, which led us to investigate the TA and PP pathways
that connect ERC and CA1 SLM, deriving from our observation
of specific reduction of the synaptic CAM Nectin-3 in the SLM of
these models [25]. Additionally, we now highlighted by unilateral
injection of AAV-Tau.4R in the ERC, the primary connections of
interest in the PP and TA pathways leading from ERC to the
hippocampus proper (Fig. S1). Our observations, combined with
literature data discussed in the next sections, demonstrated that
increased phosphorylation of protein Tau, as prelude of or for
beginning tauopathy, inflicted important functional and structural
defects within the CA1 SLM region.
The TA pathway has been overlooked in studies of the
hippocampal formation, its wiring and functions. Its physiological
importance was enforced by complex genetic manipulation in
Figure 7. DiI diffusion is reduced in brain of Tau.P301L mice. A,B: images of DiI diffusion patterns from implants in the ERC of brains from FvB
(A) and Tau.P301L mice (B) after 14 months incubation. These are representative confocal images but with strongly different contrast and
enhancement for the Tau.P301L mice (+3 gain, +4 exposure) which was needed to visualize the pathways. C. Double histological staining of DiI
pattern combined with CMC staining for myelin (blue) to locate the alvear pathway (AP) relative to the corpus callosum (CC). D. DiI staining intensity
in indicated brain regions of FvB (n = 8) and Tau.P301L mice (n = 8). Statistical analysis: Student’s t-test (unpaired, two-tailed). **p,0.01 and
***p,0.001.
doi:10.1371/journal.pone.0087605.g007
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Figure 8. Myelin defects in SLM of Tau.P301L mice. A. Representative images of the ultrastructure of myelinated axons in wild-type, Tau.P301L
and biGT mice, with myelin defects indicated by the symbols explained in the caption. B. G-ratio distribution of TA axons in SLM in wild-type FvB,
Tauopathy and Stratum Lacunosum Moleculare
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mice to specifically and reversibly inactivate synapses in CA1
formed by TA axons originating in ERC layer III [20,74].
The pathological contributions of a functional ERC-CA
connection to the temporal and spatial progression of AD was
corroborated recently in mice expressing mutant APP or protein
Tau in ERC layers II/III [13,75–77]. The comparable
Tau.P301L model failed to show behavioral defects, although
tauopathy was induced in the projection areas of the ERC [76].
Two more models expressing Tau.P301L in the ERC supported
the hypothesis that tauopathy progresses from the ERC to the
hippocampus what was attributed to the PP, which does originate
in the ERC layer II but targets mainly the DG [13,77].
Protein Tau and cognitive parameters of SLM-CA1
The various defects in the tauopathy models are substantiated
by electrophysiological and behavioral analysis. The defective
cognition of young Tau.P301L mice was extended to later age
when still preclinical with respect to progressive motor impairment
incurring at older age. The electrophysiological analysis ex vivo,
corroborated the performance of in vivo tasks that defined the
hippocampal cognitive impairment of Tau.P301L mice.
We recently described impaired levels of Nectin-3 in CA1 SLM
in Tau.P301L mice, already at young age [25]. Combined with
the timeline of cognitive defects described here, the data
demonstrate that defective Nectin-3 levels correlate with defective
hippocampal/ERC based learning and memory. Interestingly,
most recent knock-down of hippocampal Nectin-3 caused loss of
dendritic spines and spatial memory defects [78]. The combined
data underpin the important contribution of Nectin-3 in memory
processing, and the negative effects of tau pathology, even in its
most early stages of augmented phosphorylation at young age. The
latter was recently observed in post-mortem human brain of young
adults and even children [79].
Spines, synapses and Myelin affected by protein tau and
GSK3b
Needless to state that integrity of myelin sheaths is essential for
proper axonal functioning. The defective synaptic transmission at
TA synapses in the SLM can be contributed at least in part to
myelin defects, further corroborated by the aggravating contribu-
tion of GSK3b. The biGT mice at any age produce weaker LTP
than the Tau.P301L mice, indicating that postsynaptic influx of
Ca2+ through NMDA receptors and voltage-gated L-type Ca2+
channels can be affected [80,81]. The data imply that protein Tau
and GSK3b affect pre- and post-synaptic functions and mecha-
nisms of synaptic signal transmission.
Phosphorylated protein Tau did not affect dendritic spine
density in the SLM in young mice (4–6 months), in contrast with
the surprising increased spine density in other hippocampal sub-
regions of Tau.P301L mice [29]. Nevertheless, ultrastructure of
mushroom spines was affected in the SLM of clinically pre-
symptomatic Tau.P301L mice that were cognitively impaired
[26,27,29,52; this study]. The concomitant increase in PSD
volume and area in Tau.P301L mice is to be regarded as a
compensatory effect that is reminiscent of the increased PSD95
levels in patients [56]. Of note, thinning of the SLM and stratum
radiatum is correlated with cognitive decline in humans [82]. In
addition, the combination of ERC and hippocampal Tau
pathology, as well as that within the TA track, paralleled the
early cognitive decline in behavioral tasks, although to our
knowledge, no behavioral task specifically relies on the TA
pathway or on the SLM.
Defective Myelinated axons and Tauopathy
AD is by definition a neurodegenerative disease striking gray
matter. White matter pathology is rarely discussed, but comprises
myelin defects and demyelination, along with axonal degeneration
[2–4,7–9,61]. Defects were reported in myelinated PP axons
[7,10], while white matter microstructure was closely associated
with levels of protein Tau and Ab42 in CSF [83]. In animal
models, myelin defects were observed in the cortex of tau mice
[84], while combined amyloid and tau pathology caused minor
myelin defects of axons denoted as Schaffer collaterals that
connect CA3 to CA1 [85]. As a caveat, one must note that in
rodents the Schaffer collaterals are not myelinated [86–90]. Only
very recently were myelin defects described in an amyloid mouse
model [91]. The combined data indicate that myelinated axons
are affected early by amyloid but particularly by protein Tau,
before the classical AD pathology is evident [92].
Our observation of altered PPF, indicative for presynaptic
defects and therefore axonal signal disruption, as well as the
potential contribution of Nectin-3 to myelination [66,67], led us to
examine ultrastructurally the TA axons. Our data corroborates
and considerably extend the records of myelin defects in AD-
models.
Neuronal protein Tau damaged myelinated TA axons, with
dramatic aggravation by the neuronal co-expression of GSK3b.
This unexpected extra axonal damage by increased phosphoryla-
tion of protein Tau by GSK3b, is proposed to disable surrounding
oligodendrocytes in maintaining myelination of TA axons in biGT
mice. The underlying mechanisms are to be found in the complex
interplay of axons and oligodendrocytes, which remain largely
elusive and are intensely investigated in demyelinating diseases.
The prime interest is in multiple sclerosis, in which a recent
provocative hypothesis poses that degenerating axons induce
damage of surrounding myelin, not the other way around [93].
Our data on CNPase corroborate the structural defects of myelin
sheaths, in line with decreased CNPase activity in the hippocam-
pus in AD [94,95]. Also in this framework fits the remarkable
correlation of CSF biomarkers with white matter defects in AD,
promoting interest in white matter disruption as a diagnostic
criterion in AD, as measured by MRI diffusion tensor imaging
[9,82,83,96].
The combined data-sets demonstrate that increased levels of
protein Tau are sufficient to profoundly impair the functional and
Tau.P301L and biGT mice (see also Table 2). C. Quantitation of axons harboring morphological defects (left panel) and of axonal length with disrupted
myelin sheaths (right panel) in TA axons of SLM in the three genotypes. Data are mean6SEM, statistically analyzed by one-way ANOVA followed by
Bonferroni Multiple Comparison Test post hoc test; *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0087605.g008
Table 3. G - ratio of TA axons.
wild-type FvB Tau.P301L biGT
n % n % n %
O,G-ratio ,1 499 100 527 100 533 100
G-ratio ,0.7 243 48.7 309 58.6 443 83.1
G-ratio .0.7 256 51.3 218 41.4 90 16.9
doi:10.1371/journal.pone.0087605.t003
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structural organization of the entorhinal - hippocampal complex.
In particular the synapses and axons in the stratum lacunosum
moleculare were concerned, which engendered severe white
matter pathology along the myelinated axons of the transammonic
pathway. The severe extra negative impact on the white matter
defects by GSK3 implies a direct relation of axonal damage to the
functioning of surrounding oligodendrocytes, stemming from
increased phosphorylation of neuronal protein Tau.
Figure 9. Analysis of oligodendrocyte marker CNPase. A. Representative western for CNPase in hippocampal protein extracts from wild-type
FvB, Tau.P301L and biGT mice (n = 3 per genotype). The two CNPase isoforms are marked CNP1 and CNP2. B. Representative IHC images for CNPase in
SLM of the three genotypes, at ages indicated in the captions. CA1 hippocampal sub-regions of interest are defined as stratum pyramidale (py),
radiatum (SR) and stratum lacunosum molecular (SLM).
doi:10.1371/journal.pone.0087605.g009
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Supporting Information
Figure S1 Intracerebral injection of AAV-Tau.4R in ERC
highlights TA and PP pathways. Unilateral injection of AAV-
Tau.4R in the ERC of wild-type FvB mice was analyzed 14 days
post injection by IHC for human Tau with HT7 on coronal brain
sections. A. Representative images of hippocampal formation and
ERC in ipsi- and contra-lateral hemispheres. The middle panels
are enlarged views of the boxed areas in the left panels to illustrate
neuronal expression of human Tau in the ERC and CA1 sub-
regions. B. Enlarged view of the relevant strata: SR, stratum
radiatum; SLM, stratum lacunosum moleculare; ml, molecular
layer; PP, perforant pathway; gl, granular layer; hilus of the gyrus
dendatus.
(TIF)
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